Midazolam

Form: Oral Syrup

Strength: 2 mg/mL

Reference Brands: Versed(US & EU)

Category: Critical Care

Midazolam is a short-acting benzodiazepine used for procedural sedation, anesthesia induction, seizures, and ICU sedation. Available in injectable forms (1 mg/mL, 5 mg/mL), oral syrup (2 mg/mL), and buccal/rectal solutions, it is supplied in ampoules, vials, and pre-filled syringes. US brands include Versed and generics from Pfizer and Fresenius, while the EU markets Buccolam (buccal), Midazolam Accord, and B. Braun formulations. Midazolam’s rapid onset and versatility make it essential in hospitals, ambulatory centers, and emergency care. Pharma B2B platforms regularly supply Midazolam to healthcare institutions through streamlined procurement channels for anesthesia and critical care needs.